Why You Should Add Exact Sciences (EXAS) to Your Portfolio

Exact Sciences Corporation’s (EXAS) robust efforts to enhance Cologuard’s growth are poised to help it grow in the upcoming quarters. The company aims to introduce novel solutions that will revolutionize cancer detection and management, as well as boost its growth trajectory. Strong financial stability adds to the positive. Meanwhile, concerns remain over the adverse impact of macroeconomic pressures and intense competitive space.Meanwhile, heavy dependence on the Cologuard test and operating in a highly co ...